logo
Plus   Neg
Share
Email

Pentair Withdraws Q1, FY20 Guidance Amid COVID-19 - Quick Facts

Providing a business update, Pentair plc (PNR) announced Wednesday it is withdrawing its financial guidance for the first quarter and full year 2020 provided on January 28, 2020, due to the recent impacts caused by the coronavirus (COVID-19) pandemic.

Pentair has experienced reduced production in several key facilities as the result of "shelter in place" orders and suspensions of operations in several facilities due to COVID-19.

The company also said it cannot predict at this time if additional disruption in its facilities may arise or to the extent to which demand will be impacted by COVID-19.

The company plans to provide an update on full year 2020 guidance when it announces first quarter 2020 results.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that the current state of the COVID-19 pandemic in the U.S. is "really not good." The U.S. is the country worst-affected by the coronavirus and has recently seen a surge in coronavirus infections as lockdown restrictions are eased. Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Palantir Technologies Inc., the Silicon Valley big data analytics company that has handled U.S. government's certain sensitive projects, said it has confidentially filed documents with the Securities and Exchange Commission to go public. In a statement, the company said the proposed public listing of its Class A common stock is expected to take place after the SEC completes its review process.
Follow RTT